These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. Twumasi PA, Kumah S, Leach A, O'Dempsey TJ, Ceesay SJ, Todd J, Broome CV, Carlone GM, Pais LB, Holder PK. J Infect Dis; 1995 Mar; 171(3):632-8. PubMed ID: 7876610 [Abstract] [Full Text] [Related]
3. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. MacDonald NE, Halperin SA, Law BJ, Forrest B, Danzig LE, Granoff DM. JAMA; 1998 Nov 18; 280(19):1685-9. PubMed ID: 9832000 [Abstract] [Full Text] [Related]
4. Safety and immunogenicity of four doses of Neisseria meningitidis group C vaccine conjugated to CRM197 in United States infants. Rennels MB, Edwards KM, Keyserling HL, Reisinger K, Blatter MM, Quataert SA, Madore DV, Chang I, Malinoski FJ, Hackell JG, Paradiso PR. Pediatr Infect Dis J; 2001 Feb 18; 20(2):153-9. PubMed ID: 11224833 [Abstract] [Full Text] [Related]
5. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger. Campagne G, Garba A, Fabre P, Schuchat A, Ryall R, Boulanger D, Bybel M, Carlone G, Briantais P, Ivanoff B, Xerri B, Chippaux JP. Pediatr Infect Dis J; 2000 Feb 18; 19(2):144-50. PubMed ID: 10694002 [Abstract] [Full Text] [Related]
6. Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: A randomized controlled trial. MacLennan JM, Shackley F, Heath PT, Deeks JJ, Flamank C, Herbert M, Griffiths H, Hatzmann E, Goilav C, Moxon ER. JAMA; 2000 Jun 07; 283(21):2795-801. PubMed ID: 10838647 [Abstract] [Full Text] [Related]
8. Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults. Richmond P, Goldblatt D, Fusco PC, Fusco JD, Heron I, Clark S, Borrow R, Michon F. Vaccine; 1999 Nov 12; 18(7-8):641-6. PubMed ID: 10547423 [Abstract] [Full Text] [Related]
9. Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children. Pichichero M, Casey J, Blatter M, Rothstein E, Ryall R, Bybel M, Gilmet G, Papa T. Pediatr Infect Dis J; 2005 Jan 12; 24(1):57-62. PubMed ID: 15665711 [Abstract] [Full Text] [Related]
10. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Zhang Q, Choo S, Everard J, Jennings R, Finn A. Infect Immun; 2000 May 12; 68(5):2692-7. PubMed ID: 10768961 [Abstract] [Full Text] [Related]
12. Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine. Richmond P, Kaczmarski E, Borrow R, Findlow J, Clark S, McCann R, Hill J, Barker M, Miller E. J Infect Dis; 2000 Feb 12; 181(2):761-4. PubMed ID: 10669372 [Abstract] [Full Text] [Related]
13. Dosage escalation, safety and immunogenicity study of four dosages of a tetravalent meninogococcal polysaccharide diphtheria toxoid conjugate vaccine in infants. Rennels M, King J, Ryall R, Papa T, Froeschle J. Pediatr Infect Dis J; 2004 May 12; 23(5):429-35. PubMed ID: 15131466 [Abstract] [Full Text] [Related]
14. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. A randomized controlled trial. Lieberman JM, Chiu SS, Wong VK, Partidge S, Chang SJ, Chiu CY, Gheesling LL, Carlone GM, Ward JI. JAMA; 1996 May 15; 275(19):1499-503. PubMed ID: 8622225 [Abstract] [Full Text] [Related]
16. Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine. Findlow H, Southern J, Mabey L, Balmer P, Heyderman RS, Auckland C, Morris R, Miller E, Borrow R. Clin Vaccine Immunol; 2006 Apr 15; 13(4):507-10. PubMed ID: 16603620 [Abstract] [Full Text] [Related]
17. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Shinefield HR, Black S, Ray P, Chang I, Lewis N, Fireman B, Hackell J, Paradiso PR, Siber G, Kohberger R, Madore DV, Malinowski FJ, Kimura A, Le C, Landaw I, Aguilar J, Hansen J. Pediatr Infect Dis J; 1999 Sep 15; 18(9):757-63. PubMed ID: 10493334 [Abstract] [Full Text] [Related]
18. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. Fairley CK, Begg N, Borrow R, Fox AJ, Jones DM, Cartwright K. J Infect Dis; 1996 Dec 15; 174(6):1360-3. PubMed ID: 8940235 [Abstract] [Full Text] [Related]
19. Immunogenicity and reactogenicity of a group C meningococcal conjugate vaccine compared with a group A+C meningococcal polysaccharide vaccine in adolescents in a randomised observer-blind controlled trial. Choo S, Zuckerman J, Goilav C, Hatzmann E, Everard J, Finn A. Vaccine; 2000 Jun 01; 18(24):2686-92. PubMed ID: 10781855 [Abstract] [Full Text] [Related]
20. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. Leach A, Twumasi PA, Kumah S, Banya WS, Jaffar S, Forrest BD, Granoff DM, LiButti DE, Carlone GM, Pais LB, Broome CV, Greenwood BM. J Infect Dis; 1997 Jan 01; 175(1):200-4. PubMed ID: 8985221 [Abstract] [Full Text] [Related] Page: [Next] [New Search]